Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
QuintilesIMS
Accenture
Moodys
Chinese Patent Office
Julphar
US Department of Justice

Generated: May 20, 2018

DrugPatentWatch Database Preview

METOPIRONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Metopirone, and when can generic versions of Metopirone launch?

Metopirone is a drug marketed by Hra Pharma and is included in one NDA.

The generic ingredient in METOPIRONE is metyrapone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the metyrapone profile page.
Drug patent expirations by year for METOPIRONE
Pharmacology for METOPIRONE
Medical Subject Heading (MeSH) Categories for METOPIRONE
Synonyms for METOPIRONE
054M364
1-Propanone, 1,2-di-3-pyridyl-2-methyl-
1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
1-Propanone, 2-methyl-1,2-di-3-pyridyl-
1-Propanone,2-di-3-pyridinyl-
1-Propanone,2-di-3-pyridyl-
1,2-Di-3-pyridyl-2-methyl-1-propanone
2-methyl-1,2-bis(3-pyridinyl)-1-propanone
2-Methyl-1,2-bis(3-pyridyl)-1-propanone
2-methyl-1,2-bis(3-pyridyl)propan-1-one
2-methyl-1,2-bis(pyridin-3-yl)propan-1-one
2-Methyl-1,2-di-3-pyridinyl-1-propanone
2-Methyl-1,2-di-3-pyridyl-1-propanone
2-Methyl-1,2-di-3-pyridyl-1-propanone, 96%
2-METHYL-1,2-DI-3-PYRIDYL-1-PROPANONE,96%
2-Methyl-1,2-di(3-pyridinyl)-1-propanone #
2-methyl-1,2-di(3-pyridyl)propan-1-one
2-methyl-1,2-dipyridin-3-yl-propan-1-one
2-methyl-1,2-dipyridin-3-ylpropan-1-one
37245-80-0
54-36-4
A830124
AB00513955
AB00513955_07
AC1L1HKV
AC1Q1LHX
AJ-08075
AK-51541
AKOS015919707
Alliance Brand of Metyrapone
AN-41656
ANW-47874
API0003315
AX8140081
B7347
BDBM50028166
BG0427
BIDD:PXR0082
BPBio1_000824
BR-51541
BRD-K46862739-001-03-6
BSPBio_000748
C-12887
C07205
C14H14N2O
CAS-54-36-4
CC-30940
CCG-213598
CHEBI:44241
CHEMBL934
CPD000059134
CS-4879
CTK8B5187
D00410
D0Q9JT
DB01011
DR000464
DSSTox_CID_3314
DSSTox_GSID_23314
DSSTox_RID_76971
DTXSID1023314
EINECS 200-206-2
EU-0009322
EX-A1403
FJLBFSROUSIWMA-UHFFFAOYSA-N
FT-0603230
GTPL5224
HE113953
HMS1570F10
HMS2094I07
HMS2097F10
HMS2235E16
HMS3259O05
HMS3371B16
HSDB 2500
HY-B1232
I14-92873
KS-00001FBF
LS-123097
MCULE-7018205003
Mepyrapone
Metapirone
Metapyron
Methapyrapone
Methbipyranone
Methopirapone
Methopyrapone
Methopyrinine
Methopyrone
Metirapona
Metirapona [INN-Spanish]
Metopiron
METOPIRONE (TN)
Metopyrone
Metroprione
Metyrapon
metyrapone
Metyrapone (JP15/USP/INN)
Metyrapone (JP17/USP/INN)
Metyrapone [USAN:INN:BAN:JAN]
Metyrapone Alliance Brand
Metyrapone Novartis Brand
Metyrapone, >=98% (HPLC), solid
Metyrapone, United States Pharmacopeia (USP) Reference Standard
Metyraponum
Metyraponum [INN-Latin]
MFCD00006397
MLS001066377
MLS001335881
MLS001335882
MolPort-001-794-644
MYT
NC00462
NCGC00016242-01
NCGC00016242-02
NCGC00016242-03
NCGC00016242-05
NCGC00161837-01
Novartis Brand of Metyrapone
NSC 25265
NSC-25265
NSC-760076
NSC25265
NSC760076
Pharmakon1600-01506014
Prestwick0_000904
Prestwick1_000904
Prestwick2_000904
Prestwick3_000904
PubChem16052
S-6399
SAM002297829
SC-49180
SCHEMBL637432
SMR000059134
SPBio_002947
SR-01000765398
SR-01000765398-2
ST24028079
ST51006925
Su 4885
TC-136619
Tox21_110323
Tox21_110323_1
UNII-ZS9KD92H6V
W6860
ZB000400
ZINC1728
ZS9KD92H6V

US Patents and Regulatory Information for METOPIRONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hra Pharma METOPIRONE metyrapone CAPSULE;ORAL 012911-002 Aug 9, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hra Pharma METOPIRONE metyrapone TABLET;ORAL 012911-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Colorcon
Fish and Richardson
UBS
Boehringer Ingelheim
Accenture
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.